Cervical Cancer Linked to 17x Higher Anal Cancer Risk
Groundbreaking NHS research reveals a critical link between cervical and anal cancer risks in women, urging for enhanced screening protocols and greater HPV awareness to save lives.
Groundbreaking NHS research reveals a critical link between cervical and anal cancer risks in women, urging for enhanced screening protocols and greater HPV awareness to save lives.
A major study reveals the HPV vaccine has slashed cervical cancer rates by nearly 90% in the UK, heralding a potential end to the disease for future generations.
The UK is launching a major expansion of school immunisation programmes, with over 180 new vaccination centres to be established in schools across England. This initiative targets teenagers for crucial vaccines against meningitis, HPV, diphtheria, tetanus
A groundbreaking NHS trial reveals the HPV vaccine could significantly cut head and neck cancer rates, offering hope for future prevention strategies.
A father of two has revealed his battle with throat cancer caused by HPV, which he contracted through oral sex. He ignored early symptoms, leading to a late diagnosis. Learn the warning signs and how to protect yourself.
Groundbreaking research suggests the human papillomavirus (HPV) may significantly increase the risk of developing aggressive squamous cell carcinoma, a common form of skin cancer.
In a landmark decision, NHS England has extended the HPV vaccine programme to include boys aged 12-13, aiming to eradicate cervical cancer and reduce HPV-related diseases.
The NHS is rolling out a new initiative allowing patients to collect HPV test kits at GP surgeries, aiming to boost cervical cancer screening rates.
A revolutionary new HPV vaccine could save thousands of lives by preventing cancer in young people. Learn how this medical breakthrough works and who stands to benefit.
The NHS has announced an extension of the HPV vaccine programme to include boys, aiming to eradicate cervical cancer and protect against other HPV-related diseases.
New NHS data reveals London's remarkable progress in HPV vaccination, significantly reducing cancer risks. Discover how the capital is setting a national example.